Regulation of Vasopressin Secretion
加压素分泌的调节
基本信息
- 批准号:7883281
- 负责人:
- 金额:$ 37.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsAdenosineAdrenergic ReceptorAfferent PathwaysAmericanArousalBindingBlood VolumeBrain StemCellsChemosensitizationComplexCouplingCyclic AMP-Dependent Protein KinasesDataEvaluationExposure toFigs - dietaryFundingGene ExpressionGenetic TranscriptionGoalsGrantHeartHemorrhageHormonesHourHypothalamic structureImaging TechniquesLifeLobeMAP Kinase GeneMediatingMetabolismNeuronsNeurotransmittersNorepinephrineOsmolalitiesP2X-receptorPatternPhenylephrineProtein Kinase CProteinsPublicationsPurinoceptorRegulationRoleSignal TransductionSignaling MoleculeSystemTestingVasopressinsWorkdesensitizationpressurepreventreceptorreceptor couplingrelating to nervous systemresearch studyresponserhosupraoptic nucleussynergism
项目摘要
Two years of support for this project will allow us to perform the experiments proposed in Aims 3 and 4 of the original application. We have been able to complete the bulk of Aims 1 and 2 with support from the American Heart Assoc. This supported our hypothesis that simultaneous exposure of supraoptic neurons (SON) to ATP and phenylephrine induces a shift to non-desensitizing ionotropic purinergic receptor subtypes that allow ATP to sustain vasopressin (VP) release for hours. This work has been submitted for publication. The AHA grant does not provide support for Aims 3 and 4 which are crucial to understanding the mechanism by which norepinephrine can induce the shift in purinergic receptor subtype: Aim 3 is focused on identifying the 1-adrenergic receptor subtype activated by phenylephrine in SON and Aim 4 will identify the signal cascades activated by phenylephrine in SON. Identifying the 1-R signal cascade is critical to understanding why ATP activation of metabotropic purinergic receptors does not induce the same effect as phenylephrine. The ability of phenylephrine to induce sustained responses to ATP is important, because it provides a mechanism for homeostatic CNS regulatory systems to mount extended responses in order, for example, to restore blood volume following hemorrhage or for sustained arousal.
对该项目的两年支持将使我们能够执行原始应用程序的目标3和4中提出的实验。在美国心脏协会的支持下,我们已经能够完成大部分目标1和2。这支持了我们的假设,即在ATP和苯肾上腺素中简单暴露于ATP和苯肾上腺素会导致向非敏感的离子嘌呤能受体亚型转变,从而使ATP可以维持ATP维持血管固醇(VP)数小时。这项工作已提交出版。 The AHA grant does not provide support for Aims 3 and 4 which are crucial to understanding the mechanism by which norepinephrine can induce the shift in purinergic receptor subtype: Aim 3 is focused on identifying the 1-adrenagic receptor subtype activated by phenylephrine in SON and Aim 4 will identify the signal cascades activated by phenylephrine in SON.识别1-r信号级联对于理解为什么ATP激活代谢剂嘌呤能受体至关重要。苯肾上腺素诱导对ATP的持续反应的能力很重要,因为它为稳态中枢神经系统调节系统提供了一种安装扩展反应的机制,例如,在出血后恢复血液体积或持续唤醒。
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dehydration induces Fos, but not increased vasopressin mRNA in the supraoptic nucleus of aged rats.
脱水会诱导老年大鼠视上核中的 Fos,但不会增加加压素 mRNA。
- DOI:10.1016/0006-8993(94)90229-1
- 发表时间:1994
- 期刊:
- 影响因子:2.9
- 作者:Sladek,CD;Olschowka,JA
- 通讯作者:Olschowka,JA
Estrogen receptor-alpha expression in osmosensitive elements of the lamina terminalis: regulation by hypertonicity.
终板渗透敏感元件中雌激素受体α的表达:高渗调节。
- DOI:10.1152/ajpregu.00136.2004
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Somponpun,SuwitJ;Johnson,AlanKim;Beltz,Terry;Sladek,CeliaD
- 通讯作者:Sladek,CeliaD
Osmotic regulation of estrogen receptor-beta expression in magnocellular vasopressin neurons requires lamina terminalis.
大细胞加压素神经元中雌激素受体β表达的渗透调节需要终板。
- DOI:10.1152/ajpregu.00478.2003
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Somponpun,SuwitJ;Johnson,AlanKim;Beltz,Terry;Sladek,CeliaD
- 通讯作者:Sladek,CeliaD
Integration of thermal and osmotic regulation of water homeostasis: the role of TRPV channels.
- DOI:10.1152/ajpregu.00270.2013
- 发表时间:2013-10
- 期刊:
- 影响因子:0
- 作者:C. Sladek;A. Johnson
- 通讯作者:C. Sladek;A. Johnson
ATP increases intracellular calcium in supraoptic neurons by activation of both P2X and P2Y purinergic receptors.
ATP 通过激活 P2X 和 P2Y 嘌呤受体来增加视上神经元的细胞内钙。
- DOI:10.1152/ajpregu.00495.2006
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Song,Zhilin;Vijayaraghavan,Sukumar;Sladek,CeliaD
- 通讯作者:Sladek,CeliaD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CELIA D SLADEK其他文献
CELIA D SLADEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CELIA D SLADEK', 18)}}的其他基金
Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
- 批准号:
8243875 - 财政年份:2012
- 资助金额:
$ 37.37万 - 项目类别:
Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
- 批准号:
8431741 - 财政年份:2012
- 资助金额:
$ 37.37万 - 项目类别:
Neurokinin 3 Receptor: Nuclear Localization in Supraoptic Neurons
神经激肽 3 受体:视上神经元的核定位
- 批准号:
7471320 - 财政年份:2008
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6845349 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6556138 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
7047737 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6640699 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6710592 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
PILOT PROJECT--GENE REGULATION IN VASOPRESSIN NEURONS DURING AGING
试点项目——衰老过程中加压素神经元的基因调控
- 批准号:
6098263 - 财政年份:1996
- 资助金额:
$ 37.37万 - 项目类别:
相似国自然基金
基于荧光共振能量转移及指示剂置换法策略纳米组装体比率荧光识别三磷酸腺苷
- 批准号:22361028
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
S-腺苷同型半胱氨酸抑制METTL3调控m6A/miRNA-NCOA4轴致椎间盘退变的机制研究
- 批准号:82372444
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于肝脏腺苷A1受体调控的PKA-SCAP-SREBP1c通路研究知母皂苷AⅢ治疗NAFLD的分子机理
- 批准号:82374129
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
遗传变异调控可变多聚腺苷酸化影响胰腺癌风险的分子流行病学研究
- 批准号:82373663
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PUF60通过调控SET可变多聚腺苷酸化参与DNA损伤修复促进卵巢癌耐药的机制
- 批准号:82303055
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting the allosteric sodium site with novel probes for delta opioid receptor
用新型 δ 阿片受体探针靶向变构钠位点
- 批准号:
10892532 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction
鼻病毒、气道平滑肌和不可逆气流阻塞机制
- 批准号:
10735460 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
- 批准号:
10711469 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Mechanisms of spatiotemporal signaling by GPCRs
GPCR 的时空信号传导机制
- 批准号:
10722825 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Neuron-astrocyte interactions mediating ethanol and noradrenergic modulation of wake-promoting vPAG dopamine neurons
神经元-星形胶质细胞相互作用介导促醒 vPAG 多巴胺神经元的乙醇和去甲肾上腺素能调节
- 批准号:
10588136 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别: